Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY - Get Free Report) saw a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 200 shares, a growth of 100.0% from the November 15th total of 100 shares. Based on an average daily volume of 400 shares, the short-interest ratio is currently 0.5 days.
Shares of OTCMKTS APNHY opened at $9.53 on Thursday. The company has a current ratio of 1.81, a quick ratio of 1.07 and a debt-to-equity ratio of 0.30. The firm has a 50-day moving average price of $10.05 and a 200 day moving average price of $11.53. Aspen Pharmacare has a 52 week low of $8.93 and a 52 week high of $13.69.
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aspen Pharmacare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.
While Aspen Pharmacare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.